Skip to content
Find My Test

Galleri® Multi-Cancer Early Detection Test from Everlywell

Labbrary Test GradeStrong
Your Fit Score
Not calculated

Answer five questions to see how this panel matches your goals, budget, collection preferences, access, and support needs.

Calculate my fit

Labbrary's review, Fit Score, and basic comparison are free. The provider's panel, shipping, collection, clinician review, and other services are separate. About 2 minutes. No account required.

Analyze cell-free DNA methylation patterns for cancer-associated signals using a blood sample collected at Quest. If a signal is detected, the report predicts its likely origin to help guide further evaluation.

Current price
$949
Sample
Blood
Turnaround
14 to 28 days
Access
Lab Visit, Order Online
Evidence & Key Facts
Source collectedLast source check September 13, 2026

Evidence basis. This named result reflects the sources and verification evidence listed on this page as of the date shown.

Best for

Cancer Screening

Standout strength

Looks for a cancer-associated signal and, when detected, reports its likely origin.

Important watch-out

This screening test does not diagnose cancer. A detected signal requires follow-up evaluation.

Galleri® Multi-Cancer Early Detection Test from Everlywell
Labbrary Test GradeStrong
Your Fit Score
Not calculated

Answer five questions to see how this panel matches your goals, budget, collection preferences, access, and support needs.

Calculate my fit

Labbrary's review, Fit Score, and basic comparison are free. The provider's panel, shipping, collection, clinician review, and other services are separate. About 2 minutes. No account required.

Analyze cell-free DNA methylation patterns for cancer-associated signals using a blood sample collected at Quest. If a signal is detected, the report predicts its likely origin to help guide further evaluation.

Current price
$949
Sample
Blood
Turnaround
14 to 28 days
Access
Lab Visit, Order Online
Evidence & Key Facts
Source collectedLast source check September 13, 2026

Evidence basis. This named result reflects the sources and verification evidence listed on this page as of the date shown.

Best for

Cancer Screening

Standout strength

Looks for a cancer-associated signal and, when detected, reports its likely origin.

Important watch-out

This screening test does not diagnose cancer. A detected signal requires follow-up evaluation.

Labbrary+

The Test Grade. The Reason Behind It.

Strong overall documentation and usefulness, with limitations worth comparing before purchase.

A lower grade does not mean a panel is a bad personal fit. Your Fit Score can be higher when its purpose, price, sample, access, or support matches what you need.

Explore the Full Methodology
Labbrary Test GradeStrong

Next step

Check the panel or research the provider

Prices, availability, and ordering requirements can change. Confirm the current details before purchasing.

View Exact Panel on Provider SiteView Everlywell profile

Scope, both directions

Inside the Panel. Beyond the Name.

Named measurements

  • Cell-free DNA methylation patterns associated with cancer

Measured categories and focus areas

  • Cancer Screening

Important limits and omissions

  • Does not detect a signal for all cancers; false positives/negatives do occur
  • Use in addition to, not replacement of, provider-recommended screening
  • In-person venipuncture required (not at-home)
  • No state availability list on page

The full breakdown

Eight Dimensions.
One Named Result.

Open any row for the reasoning and evidence behind the named result.

The exact offer page states the test screens for DNA shed by cancer cells and is supported by clinical studies, with a false positive rate of 0.5 percent and a positive predictive value of 43.1 percent in the cited study. The performing laboratory is described only as Galleri's lab, and no named laboratory or assay certification is published on the page.

The test is recommended for adults with elevated cancer risk, such as those aged 50 or older, and for adults 22 to 49 with listed risk factors. It is not recommended for people who are pregnant, 21 or younger, or undergoing active cancer treatment.

The exact offer page names more than 50 screened cancer types across head, neck, respiratory, reproductive, urinary, digestive, skeletal, neuroendocrine, breast, skin, blood, and lymphatic categories.

A cancer-signal-detected result includes a predicted cancer signal origin to help the customer's healthcare provider determine next steps. The page states false positive and false negative results occur and that the test should be used alongside provider-recommended screening.

The page publishes the $949 price, FSA and HSA acceptance, the 50-plus cancer scope, and the stated test limitations. Refund and cancellation terms are not published on the page.

A provider reviews the request and sends the lab order to Quest Diagnostics, with blood drawn by venipuncture at more than 2,000 Quest locations nationwide. Results arrive about 2 to 4 weeks after the sample reaches the lab, and the page publishes no excluded-state list.

The exact offer page lists the test at $949 with FSA and HSA acceptance. Refund and cancellation terms are not published on the page.

Everlywell states it is HIPAA-compliant, never sells health data, and stores it securely with bank-grade encryption. The page publishes no test-specific statement about how this test's samples and data are retained, shared, or deleted.

Under the hood

Follow the Evidence.

Every published claim should trace to a dated source. Missing evidence remains visible instead of being filled with assumptions.

Source 1Recorded for this record. Last source check September 13, 2026.View source

True total cost

The Price. Plus the Details.

Pricing for Galleri® Multi-Cancer Early Detection Test
ItemCurrent disclosed priceNote
Panel$949Verify the checkout total, shipping, and collection fees before ordering.
Checkout feesNone addedEverlywell's fee record shows no order, draw or physician fee for this test.
Total at checkout$949The listed price, with no added fees on record.
HSA/FSA paymentConditional eligibility'FSA / HSA accepted.' FAQ: may use pre-tax FSA/HSA dollars; check with administrator.
Optional servicesNot confirmedClinician review, subscriptions, and retesting discounts are listed only when documented.

Price status. This record shows disclosed pricing. Checkout costs can change and should be verified before purchase.

Your data

Your Data. Your Questions.

Privacy details are scored only when source documentation is available. Unconfirmed retention, deletion, research use, or marketing practices remain unconfirmed.

Reading the labels

What Has Been Checked?

Source collected

Evidence labels stay separate from the Test Grade. They show how much source support exists for the evaluation.

The balance

The Strengths. The Tradeoffs.

Strengths

  • Looks for a cancer-associated signal and, when detected, reports its likely origin.
  • A clinician reviews your request before issuing the lab order.
  • Book an in-person blood draw at a Quest location.
  • The exact offer states that HSA/FSA payment is accepted or eligible.
  • The published workflow includes digital results and the documented support pathway.

Watch-outs

  • This screening test does not diagnose cancer. A detected signal requires follow-up evaluation.
  • Use it alongside recommended cancer screening, not as a replacement.
  • Eligibility depends on age, cancer risk, state availability, and clinician review.
  • Allow approximately two to four weeks after the sample reaches the testing laboratory. Some results may be ready in about two weeks.
  • Full state eligibility has not been confirmed. Check eligibility for your address before ordering.
  • Does not detect a signal for all cancers; false positives/negatives do occur
  • Use in addition to, not replacement of, provider-recommended screening
  • In-person venipuncture required (not at-home)
  • No state availability list on page

Take it with you

The Test Truth Card

The key facts from this review in one compact card.

Keep deciding

Galleri Multi-Cancer Early Detection Test

Mito Health

Useful

Analyzes cell-free DNA methylation patterns for a cancer-associated signal. A detected signal includes a predicted site of origin to guide diagnostic follow-up.

Price
$949
Turnaround
Not confirmed
See Labbrary reviewView Exact Panel on Provider Site
Labbrary+

The Galleri Test

Galleri

Useful

Prescription blood test that looks for cancer-associated DNA methylation signals across more than 50 cancer types. It complements routine screening and predicts an origin when a signal is detected to guide diagnostic follow-up; a negative result does not rule out cancer.

Price
$799
Turnaround
28 days
See Labbrary reviewView Official Panel Details
Labbrary+

Grail Galleri Multi-Cancer Test

Superpower

Useful

Screens a blood sample for cancer-associated DNA methylation signals and, when a signal is detected, predicts a possible tissue of origin. Positive results require diagnostic follow-up; negative results do not rule out cancer or replace routine screening.

Price
$949
Turnaround
21 days
See Labbrary reviewView Official Panel Details
Labbrary+
Compare
Run a Pre-Buy AuditExplore All TestsFind My Best-Fit Tests

Verification History

September 13, 2026Recorded source date.Source collected

Affiliate disclosure. Some outbound links may earn Labbrary a commission. Affiliate relationships never influence a Test Grade.

LABBRARY / FREE NEWSLETTER

Keep Your
Curiosity Informed.

New tests. Meaningful updates. Smarter questions to ask before you buy. Get Labbrary's free newsletter in your inbox.

Free to join. No account needed. Privacy Policy